Covid 19 Research using Clinical Trials (Home Page)
MultiStemWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (3)
Correlated MeSH Terms (2)
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
Multicenter investigation featuring an open-label lead-in followed by a double blinded,
randomized, placebo-controlled Phase 2/3 part to evaluate the safety and efficacy of
MultiStem therapy in subjects with moderate to severe Acute Respiratory Distress Syndrome
(ARDS) due to COVID-19.
NCT04367077 ARDS Biological: MultiStem Biological: Placebo
Primary Outcomes
Measure: Ventilator-Free Days Time: Day 0 through Day 28.
Measure: Safety and Tolerability as measured by the incidence of treatment-emergent adverse events as assessed by CTCAE v5.0. Time: Day 28
Secondary Outcomes
Measure: All-cause mortality Time: Day 60
Measure: Ranked hierarchical composite outcome of alive and ventilator-free Time: Day 28
Measure: Ventilator-free days Time: Day 0 through Day 60
No related HPO nodes (Using clinical trials)